MADISON, Wis. and ROCHESTER, Minn. (Dec. 3, 2019) — Exact Sciences Corp. (NASDAQ: EXAS) today announced Dr. David Ahlquist, co-inventor of Cologuard® and emeritus professor of medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, has been named a Fellow of the National Academy of Inventors (NAI).  Ahlquist’s work has helped more than 3 million people get screened noninvasively for colorectal cancer with Cologuard.

The NAI recognized Ahlquist for the impact of his career and inventions. He holds 42 issued patents in the areas of colorectal cancer screening and neoplasm detection.

The NAI Fellows Program highlights academic inventors responsible for creating or facilitating inventions that have made a tangible impact on the quality of life, economic development, and the welfare of society.

“From our first meeting 10 years ago, Dr. Ahlquist and the Mayo Clinic team focused on the power of cancer screening and early detection,” said Kevin Conroy, chairman and CEO of Exact Sciences. “Dr. Ahlquist’s vision led the way in achieving what many people thought was impossible — creating a noninvasive, highly-sensitive, and patient-friendly colon cancer screening test.”

The 2019 Fellow class represents 136 research universities, governmental, and non-profit research institutes worldwide. The Fellows collectively hold more than 3,500 issued U.S. patents.

Media Contact:

Cara Connelly, cconnelly@exactsciences.com, 614-302-5622

Investor Contact:

Megan Jones, meganjones@exactsciences.com, 608-535-8815

 About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company’s website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences or find Exact Sciences on Facebook.

Click here to read the full release.